Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study
LUCA-coach
1 other identifier
interventional
19
1 country
2
Brief Summary
The aim of this study is to investigate the acceptability, actual usage, feasibility and safety of 1) a (semi) automated PA tele coaching intervention including smartphone application and stepcounter (Fitbit Charge 4) and 2) a manual PA tele coaching program using only a stepcounter (Fitbit Charge 4) without custom smartphone application but still linked with a smartphone using the Fitbit application and to make population specific adaptations to the intervention for patients with NSCLC after lung resection surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable nonsmall-cell-lung-cancer
Started Oct 2022
Shorter than P25 for not_applicable nonsmall-cell-lung-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedFirst Posted
Study publicly available on registry
October 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedOctober 4, 2024
October 1, 2024
1.2 years
September 16, 2022
October 2, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Acceptability of the coaching programs
(i.e. to what extent patients receiving the intervention consider it as appropriate) Acceptability will be assessed through quantitative data (a project-tailored questionnaire) and qualitative data collection (patient interview with open questions). Patients will be asked to fill in a self-administered, project-tailored, multiple choice questionnaire on their experiences with the intervention. Patient interviews with open questions will be conducted by the local PA coach in each center.
9 weeks after the inclusion of the patient
Actual usage of the coaching programs
(i.e. the degree to which patients use the components of the intervention as it was designed) Actual usage of the custom application by patients will be assessed objectively through the smartphone app log (for participants in the ACP group). This will include information about completion of the app tasks and step counter data on a day-by-day basis and will be automatically collected in the back-end of the application. Actual usage of the step counter (for participants in both intervention groups) will be defined based on the presence of step count data (ie, ≥70 steps for that day). The frequency at which patients looked at their step counter will be assessed subjectively in the project-tailored questionnaire.
During the whole 8-week intervention
Feasibility of the coaching programs
(i.e. the extent to which the treatment can be successfully used within a given setting). Feasibility will be assessed through quantitative data (a project-tailored questionnaire) and qualitative data collection (patient interview with open questions). Patients will be asked to report the smartphone intervention and use of the step counter and indicate if it was not too much of a burden to work with when they are asked how they have experienced the technical aspects of the intervention. Coaches will collect contact time with patients and preparation time in a logbook in an Excel file. Also, how many times patients are contacted and the number of technical problems will be collected.
9 weeks after the inclusion of the patient
Safety of the coaching programs
Detailed information of any adverse event (AE) will be collected during the pilot phase. Description, severity, start and stop, seriousness, outcome and relation to the intervention will be described for every reported AE. If problems occur during the intervention, patients are asked to contact the coach to discuss possible AE's. If necessary, an extra visit or consultation with a physician will be scheduled. During each patient contact coaches will also seek information on AE's. All events, whether reported by the patient or noted by the coach, will be recorded in the patient's medical record and in the (e)CRF within a reasonable time after becoming aware.
During the whole 8-week intervention
Secondary Outcomes (4)
Physical activity
1 whole week after inclusion and 1 whole week after the 8-week intervention
Functional exercise capacity
1 week before the start of the intervention and immediately after the 8-week intervention
Symptoms
1 week before the start of the intervention and immediately after the 8-week intervention
Quality of Life - EORTC QLQ-C30-LC13
1 week before the start of the intervention and immediately after the 8-week intervention
Study Arms (2)
Automated Coaching Program (ACP)
EXPERIMENTALThe ACP will use the application as developed for patients with COPD and tested to be effective in this population (Demeyer et al., 2017). The program includes 1) one-to-one semi-structured interview (V1) with the coach discussing the importance of physical activity, motivation, self-efficacy, barriers, favorite activities and (coping) strategies to become more active resulting in an individual action plan; 2) step counter (Fitbit; wrist or waist worn) providing direct feedback which automatically sends data to the smartphone via blue-tooth. Patients will be asked to wear this step counter every day during the intervention; 3) smartphone coaching application, installed on a smartphone and linked to the step counter, will provide automated coaching by displaying an individual activity goal (expressed as daily step count) and daily and weekly feedback on the performance (steps) of the patient. 4) phone calls by the coaches initiated in pre-defined situations.
Manual Coaching Program (MCP)
EXPERIMENTALThe MCP includes 1) one-to-one semi-structured interview (V1) with the coach discussing the importance of physical activity, motivation, self-efficacy, barriers, favorite activities and (coping) strategies to become more active resulting in an individual action plan; 2) step counter (Fitbit, wrist or waist worn), that will be linked with a smartphone using the Fitbit application providing direct feedback. Patients can access the Fitbit application if they want to, but they will not receive personal feedback; 3) weekly phone calls by the coaches, interviewing patients on their progress, performance (steps) and feedback. The first goal is based on the physical activity level at the beginning of the coaching intervention (median of 4 days). The individual activity goal (expressed as daily step count) will be revised based on the patient's willingness to increase.
Interventions
A semiautomated tele coaching program (application installed on a smartphone device with real time feedback and motivational messages) and a step counter (Fitbit Charge 4) providing direct feedback on total daily number of steps, walking time, time in at least moderate PA and movement intensity during walking.
A telecoaching program using a step counter (Fitbit Charge 4) without this custom smartphone application but with the Fitbit application. This intervention will be more focused on weekly personal feedback from a coach by telephone.
Eligibility Criteria
You may qualify if:
- Three to nine months after a lung resection surgery for non-small cell lung cancer
- Adults (+18 year)
You may not qualify if:
- Progressive or recurrent lung cancer
- Who had other malignancies in the last 2 years
- Psychiatric disorders
- Other ongoing treatments
- Involved in or planned to start a multidisciplinary rehabilitation program
- Unable to learn to work with a new electronic device (e.g. smartphone)
- Not understanding and speaking Dutch
- Patients with comorbidities precluding them from participation in a physical activity intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- University Ghentcollaborator
- Jessa Hospitalcollaborator
- University Hospital, Ghentcollaborator
Study Sites (2)
REVAL Gebouw A
Diepenbeek, Limburg, 3590, Belgium
UZ Gent
Ghent, Oost-Vlaanderen, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris Burtin, PhD
University Hasselt
- PRINCIPAL INVESTIGATOR
Heleen Demeyer, PhD
University Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 16, 2022
First Posted
October 6, 2022
Study Start
October 1, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
October 4, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share